tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

UPB Stock Latest News

Upstream Bio management to meet with Piper Sandler
The FlyUpstream Bio management to meet with Piper Sandler
3d ago
UPB
Upstream Bio’s verekitug shows prevention of TSLP binding in respiratory disease
PremiumThe Fly
Upstream Bio’s verekitug shows prevention of TSLP binding in respiratory disease
10d ago
UPB
Positive Phase 2 Results for Upstream Bio’s Verekitug Boost Stock Potential
PremiumRatings
Positive Phase 2 Results for Upstream Bio’s Verekitug Boost Stock Potential
1M ago
UPB
Positive Buy Rating for Upstream Bio, Inc. Driven by Promising Clinical Trial Results for Verekitug
PremiumRatings
Positive Buy Rating for Upstream Bio, Inc. Driven by Promising Clinical Trial Results for Verekitug
1M ago
UPB
Upstream Bio Announces Positive Phase 2 Trial Results
PremiumCompany Announcements
Upstream Bio Announces Positive Phase 2 Trial Results
1M ago
8K
UPB
Upstream Bio’s verekitug meets endpoints in Phase 2 rhinosinusitis trial
PremiumThe FlyUpstream Bio’s verekitug meets endpoints in Phase 2 rhinosinusitis trial
1M ago
UPB
Upstream Bio, Inc. Reports Increased R&D Investments
Premium
Company Announcements
Upstream Bio, Inc. Reports Increased R&D Investments
2M ago
UPB
Optimistic Buy Rating for Upstream Bio, Inc. Driven by Promising Lead Asset and Strong Execution
Premium
Ratings
Optimistic Buy Rating for Upstream Bio, Inc. Driven by Promising Lead Asset and Strong Execution
2M ago
UPB
Positive Outlook for Upstream Bio, Inc. Driven by Promising Clinical Trial Developments
PremiumRatings
Positive Outlook for Upstream Bio, Inc. Driven by Promising Clinical Trial Developments
2M ago
UPB
Upstream Bio reports Q2 revenue $937k, consensus $317k
PremiumThe Fly
Upstream Bio reports Q2 revenue $937k, consensus $317k
2M ago
UPB
Positive Outlook for Upstream Bio, Inc. Driven by Promising Phase II Study of Verekitug in CRSwNP Treatment
PremiumRatings
Positive Outlook for Upstream Bio, Inc. Driven by Promising Phase II Study of Verekitug in CRSwNP Treatment
2M ago
UPB
Promising Outlook for Upstream Bio, Inc. as Verekitug Advances in Inflammatory Conditions
PremiumRatings
Promising Outlook for Upstream Bio, Inc. as Verekitug Advances in Inflammatory Conditions
2M ago
UPB
3 Best Stocks to Buy Now, 7/23/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 7/23/2025, According to Top Analysts
3M ago
EXE
SUN
Promising Outlook for Upstream Bio: Buy Rating Backed by Innovative CRSwNP Treatment and Strategic Leadership
Premium
Ratings
Promising Outlook for Upstream Bio: Buy Rating Backed by Innovative CRSwNP Treatment and Strategic Leadership
3M ago
UPB
Upstream Bio management to meet with Piper Sandler
Premium
The Fly
Upstream Bio management to meet with Piper Sandler
3M ago
UPB
Upstream Bio doses first patient in Phase 2 trial of verekitug in COPD
PremiumThe Fly
Upstream Bio doses first patient in Phase 2 trial of verekitug in COPD
3M ago
UPB
Six new option listings and two option delistings on July 1st
PremiumThe Fly
Six new option listings and two option delistings on July 1st
3M ago
FTV
RGC
Upstream Bio, Inc.: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
PremiumRatings
Upstream Bio, Inc.: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
4M ago
UPB
Upstream Bio, Inc.’s Verekitug: A Promising Contender in the TSLPR Antibody Space
PremiumRatings
Upstream Bio, Inc.’s Verekitug: A Promising Contender in the TSLPR Antibody Space
4M ago
UPB
Upstream Bio announces presentation of data on verekitug’s TSLP receptor
PremiumThe FlyUpstream Bio announces presentation of data on verekitug’s TSLP receptor
4M ago
UPB
Upstream Bio Holds 2025 Annual Stockholders Meeting
Premium
Company Announcements
Upstream Bio Holds 2025 Annual Stockholders Meeting
4M ago
8K
UPB
Upstream Bio appoints Price as CTO
Premium
The Fly
Upstream Bio appoints Price as CTO
5M ago
UPB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >